Artivion (AORT) Form 144: 23,356 Shares Proposed Sale ($1.00M)
Artivion, Inc. (AORT) has a Form 144 notice reporting a proposed sale of 23,356 common shares with an aggregate market value of $1,004,605.97.
Rhea-AI Filing Summary
Artivion, Inc. (AORT) has a Form 144 notice reporting a proposed sale of 23,356 common shares with an aggregate market value of $1,004,605.97. The sale is listed as occurring approximately on 08/12/2025 on the NYSE through Morgan Stanley Smith Barney LLC.
The filing shows how the shares were acquired: 6,381 as restricted stock on 02/19/2019 and 16,975 via a stock option exercise on 08/12/2025 paid in cash. The form also discloses multiple insider sales in May 2025 by JEAN F HOLLOWAY, including transactions on 05/21/2025 and 05/27/2025, each with listed share amounts and gross proceeds. The filer affirms no undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Form 144 indicating an insider sale of 23,356 shares valued at about $1.0M; transactions disclosed with acquisition dates.
The filing documents a proposed sale of 23,356 common shares on the NYSE with an aggregate market value of $1,004,605.97. Acquisition details are explicit: 6,381 restricted shares from 02/19/2019 and 16,975 from a 08/12/2025 stock option exercise paid in cash. Recent dispositions by JEAN F HOLLOWAY in May 2025 are itemized with share counts and gross proceeds. From a market-impact perspective, the filing is a standard insider disclosure with no additional financial metrics provided in this document.
TL;DR: Disclosure meets Rule 144 requirements; includes acquisition provenance and a statement negating undisclosed material information.
The notice provides the required provenance for the securities to be sold and identifies the broker and proposed exchange. It lists both restricted stock and option-exercise origins and includes a signed representation that the filer does not possess undisclosed material adverse information. The document is procedural and compliant in form; it does not contain operational or governance changes beyond the securities disposition details provided.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Artivion (AORT) report in this Form 144?
Were there recent insider sales disclosed in the filing for AORT?
Which broker and venue are named for the proposed sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.